Key terms
About ANIP
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ANIP news
Apr 17
8:12am ET
ANI Pharmaceuticals Financial Report: Key Insights Revealed
Mar 27
6:51am ET
ANI Pharmaceuticals announces launch of Levofloxacin Oral Solution
Mar 15
7:32am ET
ANI Pharmaceuticals initiated with an Overweight at Capital One
Mar 12
7:22am ET
ANI Pharmaceuticals: Current Performance Insights Revealed
Mar 05
6:24am ET
ANI Pharmaceuticals price target raised to $77 from $70 at Guggenheim
Mar 04
6:15am ET
ANI Pharmaceuticals price target raised to $83 from $73 at H.C. Wainwright
Mar 03
10:33am ET
Analysts Conflicted on These Healthcare Names: Boston Scientific (BSX), ANI Pharmaceuticals (ANIP) and Merck & Company (MRK)
Mar 01
7:56am ET
ANI Pharmaceuticals price target raised to $80 from $72 at Truist
Feb 29
6:52am ET
ANI Pharmaceuticals sees FY24 adjusted EPS $4.26-$4.67, consensus $4.33
Feb 29
6:51am ET
ANI Pharmaceuticals reports Q4 adjusted EPS $1.00, consensus 85c
Feb 27
7:51am ET
Analysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)
Feb 24
10:13am ET
ANI Pharmaceuticals Sells Ontario Facility for $14.2M USD
Feb 09
4:14am ET
ANI Pharmaceuticals Enhances Financial Disclosure Accessibility
Jan 23
6:51am ET
ANI Pharmaceuticals launches Pentoxifylline ER Tablets, USP 400mg
No recent press releases are available for ANIP
ANIP Financials
Key terms
Ad Feedback
ANIP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ANIP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range